Table 2.
Voriconazole 200 mg | Difference/ratio between means*(90% CI) | |||
---|---|---|---|---|
Parameter | n | Fasted | Fed | |
Day 1 | ||||
Cmax (ng ml−1)† | 12 | 956 ± 382 | 377 ± 388 | 39.5% |
(534–1830) | (83–1331) | (28.3, 55.1) | ||
AUCτ (ng·h ml−1)† | 12 | 3141 ± 2075 | 1787 ± 2257 | 56.9% |
(1807–8178) | (539–7159) | (46.1, 70.1) | ||
tmax (h)‡ | 12 | 1.0 ± 0.3 | 2.3 ± 0.9 | 1.2 |
(0.5–1.5) | (1.5–4.0) | (0.8, 1.6) | ||
Day 7 | ||||
Cmax (ng·ml−1)† | 12 | 2038 ± 1158 | 1332 ± 1105 | 65.4% |
(1101–4489) | (432–3902) | (51.8, 82.4) | ||
AUCτ (ng·h ml−1)† | 12 | 9598 ± 12107 | 7520 ± 11429 | 78.3% |
(4170–38545) | (2205–35350) | (70.0, 87.7) | ||
AUCt (ng·h ml−1)† | 12 | 12511 ± 23091 | 10284 ± 21372 | 82.2% |
(4838–69160) | (2703–63880) | (74.4, 90.9) | ||
AUC (ng·h ml−1)† | 7 | 19258 ± 27716 | 13065 ± 23945 | 83.4% |
(5077–70576) | (2901–64681) | (69.4, 100.2) | ||
tmax (h)‡ | 12 | 1.5 ± 0.6 | 2.6 ± 0.9 | 1.1 |
(1.0–2.5) | (1.5–4.0) | (0.5, 1.7) | ||
kel (h−1)‡ | 7 | 0.0947 ± 0.0095 | 0.1086 ± 0.0245 | 0.0098 |
(0.0850–0.1095) | (0.0771–0.1555) | (− 0.0059, 0.0255) | ||
t1/2 (h)§ | 7 | 7.3 | 6.4 | – |
(6.3–8.2) | (4.5–9.0) | |||
Accumulation ratios | ||||
Cmax (ng ml−1)† | 12 | 2.1 ± 0.9 | 3.5 ± 2.1 | 165.6% |
(1.1–4.0) | (1.7–8.0) | (123.9, 221.4) | ||
AUCτ (ng·h ml−1)† | 12 | 3.1 ± 1.8 | 4.2 ± 2.1 | 137.7% |
(1.6–8.2) | (2.5–9.5) | (116.7, 162.6) |
Ratio (%) between means shown for Cmax, AUC, AUCt, and AUCτ, difference between means for tmax and kel.
Geometric mean ± s.d. (range).
Arithmetic mean ± s.d. (range).
Harmonic mean ± s.d. (range). s.d., standard deviation.